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Abstract.  Hyaluronan (HA) and one of its cell 
binding sites, fibroblast hyaluronan binding protein 
(HABP), is shown to contribute to the regulation of 
10T1/2 cell locomotion that contain an EJ-ras-metaUo- 
thionein (MT-1) hybrid gene.  Promotion of the ras- 
hybrid gene with zinc sulfate acutely stimulates, by 
6-10-fold, cell locomotion. After 10 h,  locomotion 
drops to two- to threefold above that of uninduced 
cells. Several observations indicate increased locomo- 
tion is partly regulated by HA. These include the abil- 
ity of a peptide that specifically binds HA (HABR) to 
reduce locomotion, the ability of HA (0.001-0.1/zg/ml), 
added at 10-30 h after induction to stimulate locomo- 
tion back to the original,  acute rate,  and the ability of 
an mAb specific to a 56-kD fibroblast HABP to block 
locomotion.  Further,  both HA and HABP products are 
regulated by induction of the ras gene.  The effect of 
exogenous HA is blocked by HABR, is dose-depen- 
dent and specific in that chondroitin  sulfate or heparan 
have no significant effect. Stimulatory activity is re- 
tained by purified HA and lost upon digestion with 
Streptomyces hyaluronidase indicating that the activity 
of HA resides in its glycosaminoglycan chain.  Unin- 
duced cells are not affected by HA, HABR, or mAb 
and production of HA or HABP is not altered during 
the-experimental period. These results suggest that 
ras-transformation  activates an HA/HABP locomotory 
mechanism that forms part of an autocrine motility 
mechanism.  Reliance of induced cells on HA/HABP 
for locomotion is transient and specific to the induced 
state. 
H 
YALURONAN has  been implicated  in  a  variety  of 
disease, homeostatic, and developmental  processes 
(1,  14). Although  the manner in which it exerts its 
effects is not clear,  an increasingly  common paradigm is a 
correlation  of  an  increased  but  transient  production  of 
hyaluronan  (HA)  1 that coincides with rapid cell migration 
during  processes such as inflammation,  wound repair  (50, 
51), tumor invasion (15, 30, 35, 38), and the morphogenesis 
of a variety of tissues (4, 5, 35, 36). It has been proposed that 
HA promotes cell locomotion, in part, by interacting  with 
the cell surface (7, 38). Hyaluronan binds to the cell surface 
via several mechanisms:  ionically as a coat, by a covalently 
attached integral protein (12, 14, 35), and by specific-binding 
sites that have been proposed to include integral  glycopro- 
teins (6, 17, 21-23, 26, 45, 47). One of these proteins, termed 
fibroblast  hyaluronan  binding  protein (HABP) (41, 45) has 
been particularly implicated in the regulation of cell locomo- 
tion (40, 41). This protein is concentrated in the lamellae and 
protrusions of rapidly locomoting cells but is reduced or ab- 
sent on slowly moving or stationary  cells (42).  Reconstitu- 
tion  of stationary  embryonic  fibroblast monolayers  with 
HABP renders them responsive to HA as detected by in- 
creased random locomotion (42). 
1. Abbreviations  used in this paper:  HA, hyaluronan; HABE hyaluronan 
binding protein; HABR, hyaluron binding fragment of aggrecan. 
This paper demonstrates  that HA promotes the locomo- 
tion of 10T1/2 fibroblasts  that have been stably transfected 
with  a  mutant  ras-metallothionein  hybrid gene  (212  cell 
line;  37) only when the mutant gene is induced with heavy 
metal. Responsiveness  to HA is transitory and mediated by 
HABP as demonstrated by antibody-blocking  experiments. 
These results provide evidence for the proposal that endoge- 
nous HA production forms part of an autocrine mechanism 
for stimulating tumor cell locomotion and also provides di- 
rect  evidence  implicating  HABP as  a  mediator  of HA- 
promoted locomotion.  The 212  cell  line  will  be a  useful 
model to study the molecular mechanisms  of HA-HABP- 
driven locomotion and to dissect the role of activated ras in 
this process. The implications  for the role of HA and HABP 
in disease, homeostatic,  and developmental processes that in- 
volve cell locomotion are discussed in light of these findings. 
Materials and Methods 
Cell Culture 
The 212  ceil line was a  kind  gift of Dr.  T.  Haliotis (Cancer Research 
Laboratories, Queens University, Kingston, Canada) and is a  10T1/2 cell 
line that has been transfected with EJ-ras gene linked to a neomycin con- 
struct  and  metallothionein (MT-1) promoter (37).  Ceils  were  routinely 
maintained  in  DMEM  plus  10%  FCS  (complete medium)  containing 
geneticin G-418 (Sigma Chemical Co., St. Louis, MO; 1 mg/ml) for selec- 
tion of the neomycin construct. For experimental analysis, cell cultures 
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addition of zinc sulfate or buffer alone.  This allowed for '~50% culture 
confluence. At this degree of confluence, uninduced cells locomoted slowly. 
However, for stock cultures,  cells were routinely subcultured at a 1:50 dilu- 
tion as described by Trimble et al. (37). The promotion of the ras gene after 
the addition of zinc sulfate was confirmed by immunoprecipitation of p21ras 
and by Northern blot analysis of ras message (24; and results not shown). 
Zinc sulfate did not affect the locomotion of either the parent (10T1/2) cell 
line or a line that had been transfected with the neomycin MT-1 promoter 
construct alone (data not shown). 
Time-Lapse Cinemicrography 
Time-lapse  cinemicrography  was conducted as described previously  (10) 
using nuclear displacement as a measure of random locomotion.  Results ob- 
tained with this method were confirmed with a program ("Dynacell";  Zeiss, 
Oberkochen, FRG) that is based upon Fourier analysis of cell motility in- 
corporating such parameters as net translation, undulation, ruffling,  cell 
shape changes, and pseudopodal extension, quantified together as a motility 
index (29). For routine displacement assays, cell motility was monitored on 
a microscope  (model  IM35; Zeiss) equipped  with a  10X objective and a 
video camera. During the filming period, cells were maintained in either 
DMEM alone or complete  media (DMEM  +  10%  FCS)  that had been 
depleted  of HA  by chromatography of media  on an HABR-Sepharose 
affinity column.  HA removal was  monitored by measuring levels of this 
polymer with a Pharmacia Kit (Pharmacia Fine Chemicals, Piscataway, NJ; 
see below).  All cultures were maintained at pH 7.2. Locomotion was ob- 
served at varying times after the induction of the mutant-hybrid gene with 
zinc sulfate and filmed for 1-2-h periods.  At least 100 cells were observed 
for each assay and the results were expressed as means (#m/rain) +  SEM. 
Addition of Glycosaminoglycans 
HA was obtained from several biological sources including human umbili- 
cal cord (type I; Sigma Chemical Co.), rooster comb (Healon; Pharmacia 
Fine Chemicals), and bacteria (Diagnostic  Products  Corp., Los Angeles, 
CA).  The molecular weight for each preparation was disperse but ranged 
among 40,000 (bacterial), I million (umbilical cord), and 10 million (Hea- 
Ion).  All HA preparations were tested for the presence of contaminating 
protein and other glycosaminoglycans.  HA from the human umbilical cord 
preparation contained variable amounts of protein as well as chondroitin 
sulfate A and C (43).  HA obtained from bacteria was contaminated with 
variable amounts of protein but contained no other glycosaminoglycans; 
rooster comb preparations did not contain detectable protein or other gly- 
cosaminoglycans.  To purify HA preparations free of  possible contaminating 
growth factors and endotoxin that might affect cell locomotion,  the follow- 
ing procedures were used. HA (1 mg/rul) was chromatographed on a Sepha- 
dex G-200 column (1 cm × 60 cm; flow rate 1 ml/h) in 2.0 M NaCI buffer 
at pH 3.0 described for removing growth factors from the related glycosami- 
noglycan,  heparin (19). These conditions will also remove an HA-bound 
growth factor (16). HA, eluted in the void volume, was detected by a carba- 
zole reaction (2)  then chromatographed on an affinity  column (toxigel; 
Pharmacia Fine Chemicals) to adsorb endotoxin. The purified HA did not 
contain detectable protein as judged by absorption at 280/260 nor did it 
affect [3H]thymidine incorporation in a serum-starvation culture assay (9). 
An effect would be predicted to occur if HA was complexed with a growth 
factor that could be slowly released or if, conversely, HA bound to growth 
factors  present in growth media to render them inactive.  Heparin (pig 
mucosal lining) and chrondroitin sulfate (type A and C; shark cartilage) 
were purchased from Sigma Chemical Co.  To digest  HA to tetrnsaccha- 
rides, Streptomyces  hyaluronidase (100 IU/mi; Miles Scientific Die., Naper- 
ville, IL) was added to a 100 #g/ml solution of Healon(R) at 37°C for 48 h 
in a Na2CO3 buffer at pH 5.1 (39). 
Addition of  Antibodies and HABR 
Monoclonal antibodies were prepared against HABF by injecting mice with 
50 #g of HABP, linked to keyhole lymphocyte hvmacyanin, three times over 
a 4-wk period. 2 wk after the final injection, mice were primed by daily 
injection of 5 #g of underivatized HABP for 5 d. The spleen was then re- 
moved and hybridomas were prepared by fusing spleen cells with NS-I cells 
using 50% polyethylene glycol.  Cells were plated onto peritoneal macro- 
phage feeder layers in HAT medium. Positive colonies were cloned three 
to four times by limiting dilution and HABP binding was assessed  with an 
ELISA (45). Clones were injected into mice and nscites obtained were again 
tested for a positive reaction to HABP with an ELISA. 
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Figure 1.  (A) The locomotion of 212 cells with (A,o) or without 
(z~,o) zinc induction of the mutant ras-hybrid gene. (B) The effect 
of HA on the locomotion of zinc induced (o) and uninduced (o) 
212 cells. Random cell translocation was calculated from displace- 
ment of nuclei in a  1-h filming period.  (A) Within several hours of 
mutant gene  induction,  cells began to  translocate more  rapidly 
reaching a peak of locomotory activity at 4-6 h after gene induc- 
tion. Thereafter, locomotion dropped to ,,o15 #m/rain, a value that 
was two- to threefold higher than uninduced cells.  This rate was 
sustained for the remainder of the filming period.  (B) HA (.001 
#g/ml) had no effect on cell locomotion between 0-10 h or 30-60 h 
after gene induction (o).  However,  this glycosaminoglycan pro- 
moted locomotion of cells between 10-30 h after mutant gene in- 
duction.  HA (o) had no effect on locomotion of uninduced cells. 
Values represent the mean  +  SEM.  n  =  100 cells. 
All monoclonal antibodies isolated from ascites  were  IgGl and were 
purified  on both protein-A  Sepbarose  and HABP-Sepharose  affinity col- 
unms (45).  Of the 13 monoclonal antibodies isolated,  three were shown 
to block the locomotion of fibroblasts. One, 3T3-5, was used in this study 
to probe 212 cell responses to HA. This antibody was added for 1/2 h before 
the beginning of the 2-h filming period at dilutions of 1:100 (10 #g/nil). 
To assess specificity of antibodies,  HABP (10-200 #g/nil) was added to 
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Figure 2. The effect of antibodies to HABP and of HABR upon 212 
cell locomotion. Uninduced 212 cells (A), 212 cells induced with 
zinc for either 24 h  (B),  or for 4  h  (C),  were exposed to either 
monoclonal antibodies to fibroblast HABP (3T3-5,  3T3-7),  other 
antibodies or to HABR for 1/2 h before filming their locomotory 
behavior. The effect of these reagents on rate of locomotion in the 
presence or absence of HA (.001 #g/mD or HABP (20-200 #g/ml) 
was calculated from cell displacement during a 2-h filming period. 
Uninduccd cells (A) did not respond to antibodies or to HABR. 
The locomotion of cells that had been induced for either 24 or 4  h 
was reduced by both antibodies to HABP and by HABR in the pres- 
ence or absence of HA. The effect of HABP antibodies was reversed 
by preincubation of antibody with excess HABP.  Antiactin, anti- 
BSA, and the 3T3-7 monoclonal antibody to HABP bad no effect 
on  HA-promoted  cell  locomotion.  Values  represent  the  mean. 
n  =  100 cells. 
neutralize the antibody in sample locomotion assays. HABP added by itself 
did not, as noted previously  (42) have an effect on cell locomotion. 
Antibodies to BSA (20 #g/ml; Sigma Chemical Co.) and aetin (20 #g/ml; 
Sigma Chemical Co.) were used as controls.  Nonimmune mouse sera was 
either purified as described for antibodies to HABP or added as antisera 
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Figure 3. The effect of varying 
concentrations of HA  on in- 
duced  212  cell  locomotion. 
212  cells  were  sparsely  sub- 
cultured  and  induced  with 
zinc for 24 h. Cells were then 
exposed to increasing concen- 
trations of HA (umbilical cord) 
and the rate of locomotion was 
calculated during a  2-h film- 
ing period. Cells moved most 
rapidly in response to 0.001- 
0.1  gg/ml  HA.  Values repre- 
sent the mean. n  =  100 cells. 
at a dilution of 1:40. The proteolytic fragment of cartilage aggrccan that con- 
tains the HA-binding region (HABR) of this molecule (15), was purchased 
from Pharmacia Fine Chemicals and used at concentrations calculated  to 
bind 10 #g/ml of HA. HABR, like the antibodies,  was added 1/2 h before 
the beginning of the filming period. 
Measurement of  HA Release 
212 cells were subcultured at a 1:10 dilution in 60-mm tissue culture dishes 
(Nunc,  Rosldlde,  Denmark) containing HA-depleted  growth medium de- 
scribed above.  After  24  h,  the mutant-hybrid gene  was  induced,  and 
medium was isolated at 1, 2, 4, 6, 12, 16, 24, 48, 72, and 96 h. Media was 
also collected  at these times in uninduced cultures.  The HA present in the 
media was quantitated using HA Test 50 (Pharmacia Fine Chemicals). All 
samples were corrected  for background using HA-depleted  medium: these 
values were generally below the limits of detection (5 #g/liter). Results were 
quantified relative to HA standards prepared in this laboratory.  Linearity 
was achieved between 10-100 #g HA/liter.  Precision was determined by 
SEM and judged to be, on average,  <10% of the mean. 
lmmunofluorescence 
Induced and uninduccd 212 cells were grown on glass coverslips,  fixed for 
10 rain in freshly prepared 3% paraformaldehyde  then incubated in 1.0 M 
glycine to reduce unreactcd aldehyde groups (40). Cultures were incubated 
with mAb to HABP (3T3-7; 1 #g/ml in DMEM +  10% calf serum) for 2 h 
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Figure 4.  The effect of addi- 
tional glycosaminoglycans on 
induced 212 cell locomotion. 
212  cells  were  sparsely  sub- 
cultured  and  the  mutant  hy- 
brid  gene  was  induced  with 
zinc  sulfate  for  24  h.  Cells 
were then exposed to 0.0001- 
100  #g/ml  of  glycosamino- 
glycan. Data presented in this 
figure  included  0.001  #g/ml 
only,  but  results  were  simi- 
lax to the other concentrations 
that were examined. The rate 
of locomotion was calculated 
from  a  2-h  filming  period. 
Statistical analysis of data in- 
dicated that only HA-stimulat- 
ed cell locomotion (p <  0.05). 
Values represent the mean  + 
SEM.  n  =  100 cells. 
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from Different Biological Sources 
on Zinc-induced 212 Cell Locomotion 
Treatment  Rate of locomotion 
~u/min 5: SE) 
Umbilical cord  HA  44  +  1.2 
Purified umbilical cord HA  42  5:3.4 
HEALON  R  40  5:2.3 
Bacterial  HA  45  +  5.6 
Tetrasaccharides of HA  15  +  1.9 
Cultures of 212 cells were induced with zinc sulfate for 24 h and then exposed 
to the above treatments for an additional 2 h for analysis of cell locomotion. 
Umbilical cord HA was purified  by gel filtration  in 2 M NaCI at pH 3.0 to re- 
move putative growth factors and chromatographed on a toxigel column to re- 
move possible endotoxin contamination. Values represent means 5: SEM. n  = 
100 cells. 
at  room temperature or for  24 h at  4°C. Excess antibody was removed by 
washing and monolayers were incubated with Fab  t  RITC-anti-mouse IgG 
(Sigma Chemical Co., 1:1,000  dilution)  for I h at  room temperature. Ex- 
cess antibody was removed by washing and ceils  wcrc examined with 
epifluorescence. 
Figure 5.  Immtmofluorescent localization of HABP in (a) unin- 
duced and (b) zinc-induced 212 cells. HABP was located on 212 
cells by indirect immunofluorescence  24 h after induction of  mutant 
hybrid gene or exposure to buffer alone.  HABP was present in 
both cell populations, particularly in the ceil processes. Between 
4-24 h after induction, increased amounts of  HABP were observed. 
This occurred as both amorphous and granular staining over the 
cell body. Bar, 2.8/~m. 
Immunoprecipitation Assays 
After subculture, 212 cells were grown for 24 h  in DMEM  +  10%  FCS 
and  exposed  to  30  /~M  zinc  sulfate  or  buffer  alone  together  with 
Trans[35S]methionine/cysteine  (100/~Ci/rnl; specific activity is 1,100 Ci/ml; 
ICN Radiochemicals, Irvine, CA) for an additional 24 h. The cell layer was 
extracted with lysis buffer (10 mM Na2HPO4,  154 mM NaCI,  1% Triton 
X-100, 0.5 % sodium deoxycholate, and 0.1% sodium dodecyl sulfate, 1 #M 
leupeptin  (Sigma Chemical Co.);  Aprotinin,  1,000 KU/ml, and phenyl- 
methyl sulfonamide, 1 #g/ml (Sigma Chemical Co.) and lysates were spun 
at  25,000  g  (DuPont  Co.,  Sorvall  Instruments Div.,  Newton,  CT)  for 
60 min (24). To normalize lysates for protein content, a sample was precipi- 
tated with  10% TCA and a constant amount of radioactivity was used for 
immunoprecipitation assays. Samples were incubated with the 3T3-7 rnAb 
to HABP (0.1 #g/ml) or preimmune sera for 2 h on ice. The antibody was 
adsorbed for 2  h  with anti-mouse IgG-Staphylococcus  aureus  (10%  vol/ 
vol). Adsorbed antibody was washed in lysis buffer and then electropho- 
resed on 12.5 % SDS-PAGE. Immunoprecipitated proteins were detected by 
autoradiography. 
Results 
Induction of the Mutant Ras-Hybrid Gene-promoted 
Cell Locomotion 
Within 1-2 h after induction of the EJ-ras hybrid gene with 
zinc sulfate, an acute increase in the random locomotion of 
212 cells was observed (Fig.  1 A).  The rate of locomotion 
peaked between 2-5 h at ,~48/~m/min. By 10 h, this rate had 
dropped to 15-20/~m/min (Fig.  1 A). In contrast, the loco- 
motion of uninduced 212 cells was  '~5/~m/min,  eight- to 
ninefold less than the maximum rate of induced cells. Loco- 
motion ofuninduced cells gradually decreased to <1/~m/min 
by 72 h  after subculture (Fig.  1 A). 
The increase in locomotion resulting from induction of 
the mutant ras-hybrid gene occurred before promotion of 
[3H]thymidine incorporation (data not shown). Several ob- 
servations  suggested  that  the  increase  in  cell locomotion 
resulting from zinc induction of the mutant hybrid gene was 
regulated in part,  by the glycosaminoglycan, HA,  and by 
fibroblast HABP (Figs.  1 and 2). 
Exogenous HA-stimulated Locomotion of 
Induced Cells 
The addition of HA to 212 cells 24 h after zinc induction of 
the  mutant  hybrid  gene-stimulated  locomotion  approxi- 
mately threefold (Figs.  1 B, 2, and 3). This rate of locomo- 
tion approximated the rate observed after initial induction of 
the mutant gene (Fig. 1, A and B). Addition of HA before or 
after this time frame had no effect. Further, HA had no effect 
on locomotion of uninduced cells (Fig.  1 B). 
A response to HA was concentration dependent with max- 
imal stimulation occurring between 0.001-0.1 #g/ml (Fig. 3). 
HA was specific in its ability to promote the locomotion of 
induced 212 cells in that neither heparin nor chondroitin sul- 
fate were statistically effective (Fig. 4). Several observations 
also suggested that the effect of HA on cell locomotion was 
not because of the presence of contaminating factors possi- 
bly associated with HA preparations (Table I).  Complete 
digestion of HA to tetrasaccharides with Streptomyces hyal- 
uronidase, under conditions that controlled for protease ac- 
tivity, abolished the stimulatory effect of HA on cell loco- 
motion.  HA,  purified to  remove both growth factors and 
endotoxin, retained its ability to promote locomotion. Con- 
sistent with this, HA did not influence pH]thymidine ineor- 
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tion of HABP from lysates of 
(c) uninduced  and  (d)  zinc- 
induced 212 cells.  212 cells 
were grown to subcontluence 
and labeled with [35S]methio- 
nine for 24 h. HABP was im- 
munoprecipitated  with  mAb 
3T3-5 from cell lysates (as de- 
scribed in Materials and Meth- 
ods), resolved on SDS-PAGE, 
and processed for autoradiog- 
raphy. Zinc-induced cells con- 
tained more of an HABP com- 
plex (closed arrowhead; and 
see reference 40) than  unin- 
duced  cells.  A  smaller  pro- 
tein was also resolved in both 
uninduced  and  zinc-induced 
cells that corresponds to non- 
glycosylated HABP (open ar- 
rowhead). Lysates  immuno- 
precipitated with preimmune sera (b) did not contain significant 
amounts of either protein band. (a) Methylated ~4C standards in- 
clude (1) myosin (200 kD);  (2) phosphorylase b (97.4 kD);  (3) 
BSA (69 kD); (4) ovalbumin (46 kD); and (5) carbonic anhydrase 
(30 kD). 
poration (data not shown). HA isolated from such divergent 
species as mammals and bacteria also displayed similar stim- 
ulatory activities (Table I). 
Fibroblast HABP Mediated the Effect of HA on 
Induced Cell Locomotion 
HABR,  added at levels calculated to bind  10  #g HA,  as 
predicted from an HA test 50 kit (Pharmacia Fine Chemi- 
cals) reduced the locomotion of induced 212 cells at 4 h after 
zinc induction (Fig. 2). Further, the addition of HABR with 
exogenous  HA  negated  the  stimulatory  activity  of  this 
glycosaminoglycan (Fig. 2 B). HABR had no effect on unin- 
duced cells (Fig. 2 A). 
Several observations implicated HABP in the increased lo- 
comotion of  zinc-induced cells. A neutralizing mAb (3T3-5), 
specific to  a  56-kD  HABP  (Hardwick,  C.,  H.  P.  Hohn, 
M. Hook, E. Taylor, K. Vandeligt, L. Austen, and E. Tudey, 
manuscript submitted for publication), blocked responsive- 
ness to HA (Fig. 2 B). The rnAb had no effect on the zinc- 
induced cells activated for longer than 36 h (data not shown) 
or on the locomotion of uninduced cells (Fig. 2 A). HABP, 
added together with mAb (3T3-5), abolished the antibodies' 
inhibitory  activity.  Preimmune  mouse  sera,  anti-BSA  or 
anti-actin had no effect on cell locomotion (Fig. 2 B). 
Consistent with an involvement of HABP in responses of 
HA,  expression of this protein was increased between 4- 
36 h after promotion of the mutant-hybrid gene as indicated 
by both immunofluorescence (Fig. 5) and immunoprecipita- 
tion assays (Fig. 6) using an mAb (3T3-7, a non-blocking an- 
tibody) that is specific to the HABP.  As noted previously 
(49),  HABP occurred within a  complex of proteins  (HA 
receptor  complex)  that  electrophoresed at  the  stacking- 
separating gel interface. Assays also detected a protein of 
MWE 48-49 kD that is believed to correspond to the non- 
glycosylated form of HABP (Hardwick,  C.,  H.  P.  Hohn, 
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Figure 7. HA production of 212 ceils. 212 cells were sparsely sub- 
cultured and maintained in complete medium after zinc induction 
(o) or no treatment (o) for up to 72 h. At regular time intervals, 
medium was collected and analyzed for the presence of HA using 
the Pharmacia Test kit (Pharmacia Fine Chemicals). The accumu- 
lation of HA in media transiently increased between 0-10 h after 
mutant  hybrid  gene  induction,  dropped  and then  gradually  in- 
creased again. The transient increase in HA production was not ob- 
served for uninduced 212 cells. Rather after 10 h, HA gradually 
accumulated with time in culture. Values represent the mean  + 
SEM. n  =  4. 
M.  Hook, E. Taylor, K. Vandeligt, L. Austen, and E. Turley, 
manuscript submitted for publication). 
Increased Locomotion of Induced Cells Correlated 
with Increased HA Production 
An increase in the production of  HA occurred transiently be- 
tween  '~,1-12 h  after zinc induction of the mutant hybrid 
gene, paralleling the transient increase in cell locomotion 
(compare Figs. 1 and 7) and was similar to the concentration 
of exogenous HA required to stimulate induced 212 cells 
(Fig. 3). Production dropped to undetectable levels (<0.005 
#g/ml) by 10 h (Fig. 3) but gradually increased to 0.09 #g/ml 
24-72 h after zinc induction. 
The production of HA by uninduced 212 cells was unde- 
tectable during the first 18 h but rose gradually to 0.06 #g/ml 
by 72 h after subculture: HA production was always  lower 
than that of induced cells (Fig. 7). 
Discussion 
Expression of a ras oncogene has previously been shown to 
correlate with increased cell locomotion (28, 48). We show 
here that acute induction of this mutant gene activates an au- 
tocrine HA-HABP-mediated locomotory mechanism. Data 
indicate that this mechanism is specific to the induced state, 
transient,  and  accounts  for  ~50%  of the  observed  ras- 
induced increase in locomotion. With time however, it is 
disassembled as indicated by a reduction in autocrine pro- 
duction of HA, followed by a loss of responsiveness to both 
exogenous HA and antibodies to HABP. 
Several characteristics of the 212 cell locomotion occur- 
ring  in  response  to  HA  are  noteworthy.  Firstly,  HA- 
HABP-driven locomotion is associated with the initiation of 
rapid locomotion. A similar paradigm has been observed in 
vivo where increased production of HA is associated with 
the onset of locomotion (15, 35, 38, 50). Secondly, HA and 
a functional HABP are transiently produced, as has been ob- 
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212 ceils on HA, as reflected by their lack of responsiveness 
to this polymer, correlates with insensitivity of cells to the 
mAb specific for HABP (data not shown). Both decreases in 
HABP expression,  which occur with chronic induction of 
the ras gene, and functional alterations of this binding site 
may contribute to insensitivity to HA. 
The ability of antibodies to HABP to block locomotion is 
consistent with several previous observations.  In most cell 
types, expression of HABP correlates with rapid locomotion 
(40, 41) and this protein is localized to areas of cells that are 
relevant to locomotion, such as ruffles and lamellipodia (40, 
41). Polyclonal antibodies to HABP block HA-promoted mi- 
gration of embryonic ductus aorta smooth muscle cells into 
collagen  gels  (3).  Conversely,  reconstitution of confluent 
contact inhibited chick heart fibroblasts  with  HABP  (42) 
permits stimulation by HA. 
In 212  cells,  changes in expression of HABP  does  not 
completely  correlate  with  their  lack  of response  to  HA. 
Uninduced 212 cells do express some HABP, but do not re- 
spond to either HA or mAb to HABP.  Lack of response is 
unlike other fibroblasts we have studied, where expression 
of HABP correlates strongly with response to these regula- 
tors. Rather,  they resemble embryonic vascular endothelial 
cells which express small amounts of HABP but do not re- 
spond to HA or anti-HABP (3). Possibly either a threshold 
amount of HABP is required to affect locomotory responses 
(45) or HABP can, as eluded to above, occur in "functional" 
and "nonfunctional" states. 
Perturbation  of  the  HA-driven  locomotion  by  either 
HABR  or  mAb-HABP  does  not completely  abolish  ras- 
induced increases  in motility.  Ceils  clearly use additional 
mechanisms  for locomotion that are also regulated by the 
mutant hybrid gene and these alternate mechanisms appear 
to predominate with chronic induction of the gene. 
The molecular mechanisms by which HA-HABP interac- 
tions promote cell locomotion are not clear.  Hyaluronan has 
long been proposed to function in the locomotory cycle as 
a detaching factor because of its physicochemical properties 
(7, 14, 38, 50). However, both the low concentration at which 
this  glycosaminoglycan promotes  locomotion (at  approxi- 
mately the KD for HABP;  45)  and a previous observation 
that HA can promote protein phosphorylation (39) suggest 
additional  molecular  mechanisms.  The  last  possibility  is 
consistent  with  the  observation  that HABP  is  complexed 
with a protein kinase at the cell  surface (39) and with the 
ability of chemotactic factors (33, 52) and other extracellular 
matrix molecules (12, 25, 49) involved in cell locomotion to 
promote protein phosphorylation. 
The  mechanisms  by which the ras gene might regulate 
HA/HABP are unknown, but activation of the ras gene has 
been associated  with release  of autocrine mobility factors 
(18, 33, 34) and growth factors, both of which may promote 
HA production (11, 44). Other factors such as HA-stimulat- 
ing activities (HASA), present in serum (8, 44) may also be 
controlled by the ras  gene. 
In summary,  an oncogene-transformed fibroblast model 
that relies upon HA and HABP for locomotion is described. 
These results implicate HA and fibroblast HABP as impor- 
tant regulators of cell locomotion during oncogenic transfor- 
mation and are consistent with a recent report noting that HA 
is required for tumor cells to respond to a tumor motility fac- 
tor (52). This model will be useful in dissecting the molecu- 
lar mechanisms  by which HA and one of its cell  binding 
sites,  HABP, acts to promote cell locomotion. 
The authors thank Dr. M. Hook and M. Hollenberg for critical reading of 
the manuscript. 
This work was supported by the National Cancer Institute of Canada and 
Medical Research Council of Canada grants to E. Turley. 
Received for publication 23 May 1990 and in revised form 12 November 
1990. 
References 
1. Bansal, M. K., and R. M. Mason. 1986. Evidence for rapid metabolic turn- 
over of hyaluronate synthetasc in swarm rat chondrosarcoma chondrn- 
cytes. Biochem. J.  236:515-519. 
2. Bitter,  T., and H. M. Muir.  1963.  A modified carbazole reaction.  Anal 
Biochem.  4:330-334. 
3. Boudreanx, N., E.  A. Turley, and M.  Rabinovitch.  1990.  Fibronectin, 
Hyaluronan and a  Hyaluronan binding protein contribute to increased 
ductus arteriosis  smooth muscle cell migration. Dev. Biol. In press. 
4. Copp, A. J., and M. Bcrnfield.  1988a.  Glycosaminoglycans vary in ac- 
cumulation  along the neuraxis during spinal neurulation in the mouse em- 
bryo. Dev.  Biol. 130:573-582. 
5. Copp,  A.  J.,  and  M.  Bcrnfield.  1988b.  Accumulation  of  basement- 
membrane  associated hyaluronate  is reduced in the posterior neurnpore 
region of mutant (curly tail) mouse embryos developing spinal neural tube 
defects. Dev. Biol. 130:583-590. 
6. Crossman, M. V., and R. M. Mason. 1990. Purification  and characteriza- 
tion of a hyaluronan-binding  protein from rat chondrosarcoma. Biochem. 
J.  266:399-406. 
7. Culp, L. A. 1976. Molecular composition and origin of substratc-attached 
material from normal and virus-transformed cells. J. Supramol. Struct. 
5:239-255. 
8. Decker, M., E. S. Chin, C. Dollbaun, A. Moiin, J. Hall, R. Spendcove, 
M. T. Longaker, and R. Stern.  1989. Hyaluronic acid stimulatory activity 
in sera from the bovine fetus and from breast cancer patients.  Cancer Res. 
49:2499-3505. 
9. Edwards, D. R., and D. T. Denhardt. 1985. A study of mitochondrial and 
nuclear  transcription  with  cloned  eDNA  probes.  Exp.  Cell Res. 
157:127-143. 
10. Erickson, C. A., and E. A. Turley. 1983.  Substrata formed by combina- 
tions of extracellular  matrix components alter neural crest cell motility 
in vitro. J.  Cell $ci. 61:299-323. 
11. Erickson, C. A., and E. A. Turley. 1987. The effects of Epidermal Growth 
Factor  on  Neural  Crest  Cells  in  Tissue  Culture.  Exp.  Cell  Res. 
169:267-279. 
12. Ferrell,  J.  E.,  and G.  S.  Martin.  1989.  Tyrosine-specific  protein  pbos- 
pborylation is regulated by glycoprotein 1 lb and 11 la in platelets.  Proc. 
Natl. Acad.  Sci. USA. 86:2234-2238. 
13. Deleted in proof. 
14. Hook, M., L. Kjellen, S. Johansson, and J. Robinson. 1984. Cell-surface 
glycosaminoglycans. Annu. Rev. Biochem.  53:847-869. 
15. Iozzo, R. V. 1985. Proteoglycans: structure, function and role in neoplasia, 
Lab.  Invest.  53:373-396. 
16. Keating,  A.,  E.  Turley,  S.  Saragosa,  and C.  Nijuen.  1990.  Effect  of 
glycosaminoglycans on haematopoietic  progenitor cells: compartmental- 
ization  of GMCSF by hyaluronic acid. Exp.  Hematol  (NY). In press. 
17. Lanrent, T. C., and J. R. E. Fraser.  1986. The properties and turnover of 
hyaluronan. Functions  of the proteoglycans. Ciba Found.  Syrup. 124: 
9-29. 
18. Liotta, L. A., R. Mandler, G. Murano, D. A. Katz, R. K. Gordon, P. K. 
Chiang, and E. Sehiffmann. 1986. Tumor cell anlocrine motility factor. 
Proc.  Natl. Acad.  Sci. USA. 83:3303-3306. 
19. Lobb, R. R., and J. W. Fett. 1984. Purification  of two distinct growth fac- 
tors from bovine neural tissue by heparin-altinity chromatography.  Bio- 
chemistry.  23:2960-2966. 
20. Longaker, M. T., M. R. Harrison, J. C. Langer, T. M. Crombleholme. 
M. Decker, E. D. Verrier, R. Spendlove, and R. Stern.  1989.  Studies 
in fetal wound healing: I. A factor in fetal serum that stimulates deposition 
of hyaluronic acid.  Pediatr.  Surg. Int.  24:793-798. 
21. McCarthy,  M.  T.,  and  B.  P.  Toole.  1989.  Membrane-associated 
hyaluronate-binding activity  of chondrosarcoma  chondrocytes. J.  Cell. 
Physiol.  141:191-202. 
22. McGary, C.  T.,  R.  H.  Raja, and P.  H. Weigel.  1989.  Endocytosis of 
hyaluronic acid by rat liver endothelial  cells. Biochem.  J. 257:875-884. 
23. Moczar, M., M. F. Poupon, and E. Moczar. 1990.  Hyaluronate-binding 
proteins  in weakly and highly metastatic variants of rat rhabdomyosar- 
coma cells.  Clin. & Exp. Metastasis.  8:129-140. 
24. Myrdal, S. M., and N. Auersperg. 1985. p21 ras heterologous localization 
in transformed cells. Exp.  Cell Res.  159:441-450. 
The Journal of Cell Biology,  Volume  112,  1991  1046 25. Nakamura, S. I., and H. Yamamura. 1989. Thrombin and collagen induce 
rapid phosphorylation of a common set of cellular proteins on tyrosine 
in Human Platelets.  J.  Biol.  Chem. 264:7089-7091. 
26. Newell, P. C., G. N. Europe-Finner, N. V. Small, and G. Liu. 1988. Inosi- 
tol phosphates, G-proteins and ras genes involved in chemotactic signal 
transduction of Dictyostelium. J.  Cell. Sci. 89:123-127. 
27. Orkin, R. W., W. Knudson, and B. P. Toole.  1985. Loss of hyaluronate- 
dependent coat during myoblast lesion. Dee. Biol. 107:527-530. 
28. Partin, A. W., J. T. lsaacs, B. Trieger, and D. S. Coffey. 1988. Early cell 
motility changes associated with an increase in metastatic ability  in rat 
prostatic cancer cells transfected with the v-Harvey-ras oncogene. Can- 
cer Res. 48:6050-6053. 
29. Partin, A. W., J. S. Schoemiger, J. C. Mohler, and D. S. Coffey. 1989. 
Fourier analysis of cell motility: correlation of motility with metastatic 
potential.  Proc.  Natl. Acad. Sci. USA. 86:1254-1258. 
30. Pauli, B. U., D. E. Schwartz, E. J. Thonar, and K. E. Kuetmer. 1983. Tu- 
mor  invasion and  host extracellular matrix.  Cancer Metastasis  Rev. 
2:129-152. 
3 I. Prehn, P. 1983. Synthesis of hyaluronate in differentiated  teratocarcinoma 
cells: characterization of the synthase. Biochem. J.  211 : 181-189. 
32. Schor, S. L., A. M. Schor, A. M. Grey, J. then, G. Rushton, M. E. Grant, 
and I. Ellis. 1989. Mechanisms  of action of  the migration stimulating  fac- 
tor produced by fetal and cancer patient fibroblasts:  Effect on hyaluronic 
acid synthesis. In  Vitro Cell. & Dev.  Biol. 25:737-745. 
33. Segal, J. E., and G. Gerish. 1989. Genetic approaches to cytoskeleton func- 
tion and the control of cell motility. Curr. Opin. Cell Biol. 1:44-50. 
34. Stoker, M., and M. Perryman. 1985. An epithelial  scatter factor released 
by embryo fihroblasts. J.  Cell Sci. 77:209-224. 
35. Toole, B.  P.  1982.  Developmental role of hyaluronate. Connect.  Tissue 
Res. 10:93-100. 
36. Toole,  B.  P.,  S.  F.  Munaim,  S.  Welles, and  C.  B.  Knudson.  1989. 
Hyaluronate-cell interactions and growth factor regulation of hyaluronate 
synthesis  during limb development. Biology of Hyaluronan. Ciba Found. 
Syrup. 143:138-149. 
37. Trimble, W. S., P. W. Johnson, N. Hozumi, andJ. C. Roder. 1986. Induc- 
ible  cellular transformation by a  metallothionein-ras hybrid oncogene 
leads to natural killer  cell susceptibility. Nature  (Lond.). 321:782-784. 
38. Turley, E. A.  1984.  Proteoglycans and cell adhesion: their putative role 
during tumorigenesis. Cancer Metastasis Rev. 3:325-339. 
39. Turley, E. A. t989. Hyaluronic acid stimulates protein kinase activity  in 
intact  cells  and  in  an  isolated  protein  complex.  J.  Biol.  Chem. 
264:8951-8955. 
40. Tufley, E.  A., and J.  Torrance.  1985.  Localization of hyaluronate and 
hyaluronate binding protein on motile and non-motile fibroblasts.  Exp. 
Cell Res.  161:17-28. 
41. Turley, E., and N. Auersperg. 1989. A hyaluronate binding protein tran- 
siently codistributes with p21 k-~'~ in cultured cell lines. Exp.  Cell Res. 
181:340-348. 
42. Turley, E. A., P. Bowman, and M. A. Kytryk. 1985. Effects of hyaluronate 
and hyaluronate binding proteins on cell motility and contact behavior. 
J.  Cell Sci. 78:133-145. 
43. Turley, E. A., C. A. Erickson, and R. P. Tucker. 1985. The retention and 
ultrastmctural appearance of various extracellular matrix molecules in- 
corporated into three-dimensional hydrated collagen lattices. Dee. Biol. 
109:347-369. 
44. Turley, E. A., M. D. Hollenberg, and R. M. Pratt. 1985. Effect of epider- 
mal growth factor/urogastrone on glycosaminoglycan synthesis and ac- 
cumulation in  vitro in  the  developing mouse palate.  Differentiation. 
28:279-285. 
45. Turley, E.  A., D. Moore, and L. J.  Hayden.  1987.  Characterization of 
hyaluronate binding proteins isolated from 3T3 and murine sarcoma  virus 
transformed 3T3 cells. Biochemistry.  26:2997-3005. 
46. Turley, E.  A., S. Roth, and J. A. Weston. 1989.  A model system that 
demonstrates interactions among extracellular matrix macromolecules. 
Connect.  Tissue Res.  23:221-235. 
47. Underhill, C. B., S. J. Green, P. M. Lomoglio, and C. Tame. 1987. The 
hyaluronate receptor is identical  to a glycoprotein of Mr 85,000 (SP85) 
as shown by a monoclonal antibody that interferes with binding activity. 
J.  Biol. Chem. 262:13142-13146. 
48. Volk, T., B. G-eiger, and A. Raz. 1984.  Motility and adhesive properties 
of high and low metastatic neoplastic cells. Cancer Res.  44:811-824. 
49. Watson, S. P., B. Reep, B. T. McConnell, and E. G. Lapetina. 1985. Col- 
lagen stimulates [3H]inositol  triphosphate formation in  indomethacin- 
treated human platelets. Biochem. J.  226:831-837. 
50. Weigel, P. H., G. M. Fuller, and R. D. LeBoeuf. 1986. A model for the 
role of hyaluronic acid and fibrinogen in the early events during the 
inflammatory response and wound healing. J. Theor. Biol. 119:219-234. 
51. Weigei, P. H., S. J. Frost, R. D. LeBoeuf, and C. T. McGary. 1989. The 
specific interaction between fibr~nogen and hyaluronan: possible conse- 
quences in haemostasis, inflammation and wound healing. Biology of 
Hyaluronan. Ciba Found. Symp. 143:248-264. 
52. Zigmund, S. H. 1989.  Cell locomotion and chemotaxis. Curr. Opin. Cell 
Biol.  1:80-86. 
Turley et al. Regulation of Locomotion by Hyaluronan and HABP  1047 